BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32152268)

  • 21. MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8.
    Ge X; Niture S; Lin M; Cagle P; Li PA; Kumar D
    Sci Rep; 2021 Mar; 11(1):5660. PubMed ID: 33707587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma.
    Yang L; Peng X; Jin H; Liu J
    Gene; 2019 May; 697():94-102. PubMed ID: 30794914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impairment of hepatic growth hormone and glucocorticoid receptor signaling causes steatosis and hepatocellular carcinoma in mice.
    Mueller KM; Kornfeld JW; Friedbichler K; Blaas L; Egger G; Esterbauer H; Hasselblatt P; Schlederer M; Haindl S; Wagner KU; Engblom D; Haemmerle G; Kratky D; Sexl V; Kenner L; Kozlov AV; Terracciano L; Zechner R; Schuetz G; Casanova E; Pospisilik JA; Heim MH; Moriggl R
    Hepatology; 2011 Oct; 54(4):1398-409. PubMed ID: 21725989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R.
    Ge YY; Shi Q; Zheng ZY; Gong J; Zeng C; Yang J; Zhuang SM
    Oncotarget; 2014 Aug; 5(15):6218-28. PubMed ID: 25026290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.
    Luo T; Fu J; Xu A; Su B; Ren Y; Li N; Zhu J; Zhao X; Dai R; Cao J; Wang B; Qin W; Jiang J; Li J; Wu M; Feng G; Chen Y; Wang H
    Autophagy; 2016 Aug; 12(8):1355-71. PubMed ID: 25905985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease.
    Vansaun MN; Mendonsa AM; Lee Gorden D
    PLoS One; 2013; 8(9):e73054. PubMed ID: 24039859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autophagy, NAFLD and NAFLD-Related HCC.
    Wu WKK; Zhang L; Chan MTV
    Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immature colon carcinoma transcript-1 promotes cell growth of hepatocellular carcinoma via facilitating cell cycle progression and apoptosis resistance.
    Chang W; Yu Z; Tian M; Lin X
    Oncol Rep; 2017 Dec; 38(6):3489-3496. PubMed ID: 29130100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells.
    Li W; Dong X; He C; Tan G; Li Z; Zhai B; Feng J; Jiang X; Liu C; Jiang H; Sun X
    J Exp Clin Cancer Res; 2019 May; 38(1):183. PubMed ID: 31053148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.
    Wang LL; Jin XH; Cai MY; Li HG; Chen JW; Wang FW; Wang CY; Hu WW; Liu F; Xie D
    Cancer Lett; 2018 Feb; 414():71-80. PubMed ID: 29126912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
    Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
    Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
    J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective effect of the Y220C mutant p53 against steatosis: good news?
    Gori M; Barbaro B; Arciello M; Maggio R; Viscomi C; Longo A; Balsano C
    J Cell Physiol; 2014 Sep; 229(9):1182-92. PubMed ID: 24395441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hedgehog signaling pathway regulates autophagy in human hepatocellular carcinoma cells.
    Wang Y; Han C; Lu L; Magliato S; Wu T
    Hepatology; 2013 Sep; 58(3):995-1010. PubMed ID: 23504944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells.
    Kiyono K; Suzuki HI; Matsuyama H; Morishita Y; Komuro A; Kano MR; Sugimoto K; Miyazono K
    Cancer Res; 2009 Dec; 69(23):8844-52. PubMed ID: 19903843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potent effects of dioscin against hepatocellular carcinoma through regulating TP53-induced glycolysis and apoptosis regulator (TIGAR)-mediated apoptosis, autophagy, and DNA damage.
    Mao Z; Han X; Chen D; Xu Y; Xu L; Yin L; Sun H; Qi Y; Fang L; Liu K; Peng J
    Br J Pharmacol; 2019 Apr; 176(7):919-937. PubMed ID: 30710454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.
    Tai WT; Shiau CW; Chen HL; Liu CY; Lin CS; Cheng AL; Chen PJ; Chen KF
    Cell Death Dis; 2013 Feb; 4(2):e485. PubMed ID: 23392173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation.
    Niture S; Lin M; Odera JO; Moore J; Zhe H; Chen X; Suy S; Collins SP; Kumar D
    Int J Biochem Cell Biol; 2021 Jan; 130():105885. PubMed ID: 33227392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.